DSIP: research overview

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring peptide first identified in brain studies. It is mainly researched for its role in sleep regulation, stress modulation, and circadian rhythm support.

How it's studied to work

DSIP is not a classic sedative — research explores whether it regulates the brain's sleep systems instead, including neurotransmitters involved in sleep (GABA, dopamine, serotonin pathways), normalization of the circadian sleep-wake cycle, and reduction of stress-related overactivation of the nervous system.

Areas of research interest

Research and anecdotal interest centers on sleep depth, night waking, stress-related sleep disruption, and indirect overnight-recovery effects linked to better sleep.

Who might consider researching it, and who should not

Discussed in the context of sleep onset or maintenance issues, stress-related insomnia, and disrupted circadian rhythm (e.g. shift work). It should not be used by anyone pregnant or breastfeeding, anyone with a severe psychiatric disorder without supervision, anyone with an undiagnosed sleep disorder such as sleep apnea, or anyone on multiple sedative medications given unclear interaction risk.

Reported effects to be aware of

Reported effects are generally mild but not well studied — headache, vivid dreams, daytime drowsiness, mild fatigue, and rare paradoxical (worsened) insomnia have been reported.